Skip to main content
logo
10x Genomics, Inc. (TXG)
NASDAQ: TXG · Real-Time Price · USD
19.15
0.00 (0.00%)
At close: Feb 11, 2026, 4:00 PM EST
19.40
+0.25 (1.28%)
After-hours: Feb 11, 2026, 6:19 PM EST

10x Genomics Revenue

10x Genomics had revenue of $149.00M in the quarter ending September 30, 2025, a decrease of -1.75%. This brings the company's revenue in the last twelve months to $641.81M, up 1.92% year-over-year. In the year 2024, 10x Genomics had annual revenue of $610.79M, down -1.28%.

Revenue (ttm)
$641.81M
Revenue Growth
+1.92%
P/S Ratio
3.68
Revenue / Employee
$491,435
Employees
1,306
Market Cap
2.42B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024610.79M-7.94M-1.28%
Dec 31, 2023618.73M102.32M19.81%
Dec 31, 2022516.41M25.92M5.28%
Dec 31, 2021490.49M191.65M64.13%
Dec 31, 2020298.85M52.95M21.53%
Dec 31, 2019245.89M99.58M68.06%
Dec 31, 2018146.31M75.23M105.83%
Dec 31, 201771.09M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Teladoc Health2.53B
Privia Health Group2.04B
HealthEquity1.29B
Omnicell1.18B
Waystar Holding1.04B
GoodRx Holdings800.65M
Doximity637.78M
Hinge Health587.86M
Revenue Rankings

TXG News

More News